Scientist removed as director of federal agency working on coronavirus vaccine to file whistleblower complaint
Attorneys for Rick Bright, the federal scientist who once led the department leading coronavirus vaccine development, said on Thursday he is filing a whistleblower complaint, alleging that he was ousted because he did not promote a drug treatment touted by President Trump.
Bright was removed on Tuesday as director of the Biomedical Advanced Research and Development Authority, and given a job at the National Institutes of Health with fewer responsibilities. Bright's lawyers said they will file formal complaints with the inspector general of the Health and Human Services Department and the federal Office of Special Counsel, which will detail "the retaliatory treatment to which he was subjected by HHS political leadership after raising appropriate science-based concerns about White House pressure on treatment and vaccines related to the COVID-19 pandemic."
The filings will also "make clear that Dr. Bright was sidelined for one reason only — because he resisted efforts to provide unfettered access to potentially dangerous drugs, including chloroquine, a drug promoted by the administration as a panacea, but which is untested and possibly deadly when used improperly. The facts and concerns raised by Dr. Bright are compelling and well-documented and soon they will be public."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Bright released a statement on Wednesday saying he believes he was removed as director after he made it known he felt "the billions of dollars allocated by Congress to address the COVID-19 pandemic" should be put "into safe and scientifically vetted solutions, and not in drugs, vaccines, and other technologies that lack scientific merit." When asked about this by reporters, Trump said he had never heard of Bright.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
An ailing Pope Francis – and the vultures circling in the Vatican
Talking Point Caught between his progressive inner circle and an influx of conservatism, the Holy Father should 'brace' himself for a battle
By The Week UK Published
-
Crossword: February 2, 2025
The Week's daily crossword
By The Week Staff Published
-
Sudoku medium: February 2, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published